Nanoportal Biotech Announces Presentations at ASH 2024: Efficient Generation of CAR-T Cells Using t

Nanoportal Biotech presented our groundbreaking proof-of-concept data at the 2024 Annual Meeting of the American Society of Hematology (ASH), demonstrating the successful generation of CAR-T cells utilizing the world’s first coacervate-based gene delivery system. The presentation also featured the engineering of various primary cell types, including NK cells, CD34+ hematopoietic stem cells, with this innovative system, marking a significant advancement in cell therapy manufacturing.

 Oral Presentation Details:

• Title: Efficient Generation of CAR-T Cells Using  the First Coacervate-Based Gene Delivery System

• Type: Oral Presentation

• Session: 711. Cell Collection and Manufacturing of      HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Innovations in      Mobilization, Collection, and Manufacturing for Cellular Therapies

• Topics: Research, Fundamental Science,      Translational Research, Chimeric Antigen Receptor (CAR)-T Cell Therapies,      Gene Therapy, Treatment Considerations, Biological Therapies, Emerging  Technologies, Technology and Procedures, Gene Editing

For more information, follow us on our official WeChat account or contact our support team: proteanfect@nanoportalbio.com.